Characterization of the most promising fraction of Swietenia macrophylla active against myotoxic phospholipases A2: identification of catechin as one of the active compounds
DOI:
https://doi.org/10.17533/udea.vitae.v23n2a05Keywords:
Swietenia macrophylla, catechin, molecular docking simulation, snakebite, ViperidaeAbstract
Background: The pharmacological effects produced by snakebite accidents involve the actions of several enzymes, of which those of the phospholipases A2 (PLA2) exhibit a wide variety of effects such as edema and myotoxicity. Some plant extracts have been antagonists of crude snake venoms and toxins. Based on promising bioactivity, Swietenia macrophylla King was selected for further studies. Objective: The purpose of this study was to identify the PLA2 inhibitors present in the crude extract of S. macrophylla that could be promising leads in neutralizing the local effects of ophidian accidents. Methods: Bioassay-guided fractionation of the ethanolic extract of the leaves of S. macrophylla lead to the detection of (+)-catechin, characterized through gas chromatography coupled with mass spectrometry (GC-MS), and confirmed by HPLC. The PLA2 inhibitory activity was measured with the Dole method and a spectrophotometric assay with 4-Nitro-3-octanoyloxy-benzoic acid (4N3OBA). Cytotoxicity was done on C2C12 murine myoblast. Results: Fraction F5 and (+)-Catechin inhibited the PLA2 activity of B. asper venom, in a dose-dependent way. In addition, (+)-Catechin showed an inhibition level of 83.1 ± 3.1 % of the enzymatic activity of one PLA2 purified from the venom of Crotalus durissus cumanensis using 4N3OBA as substrate. Also the ethanolic extract and fraction F5 showed inhibition of the cytotoxicity induced by the Bothrops atrox venom and their Lys 49 PLA2 (80 and 100% respectively). Molecular docking results suggested that that OH from 4´ and 5’ carbons of (+)-catechin could form hydrogen bonds with carboxylate moiety of residue Asp49, while OH from 5 could form a hydrogen bond with Asn 6. Additional Van der Waals interactions were also proposed. Conclusion: Swietenia macrophylla exhibited strong inhibitory activity against PLA2s enzymes. Catechin, the most abundant metabolite in the active fraction F5, is proposed as one of the compounds responsible for the bioactivity.
Downloads
References
Chippaux JP. Estimating the global burden of snakebite can help to improve management. PLoS Med. 2008 Nov; 5(11): e221.
Williams D, Gutiérrez JM, Harrison R, Warrell DA, White J, Winkel KD, et al. The Global Snake Bite Initiative: an antidote for snake bite. The Lancet. 2010 Jan 2; 375: 89-91.
Kasturiratne A, Wickremasinghede AR, da Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: a literature analysis and modeling based on regional estimates of envenoming and deaths. PLoS Med. 2008 Nov 4; 5(11): e218.
Gutiérrez JM, León G, Rojas G, Lomonte B, Rucavado A, Chaves F. Neutralization of local tissue damage induced by Bothrops asper(terciopelo) snake venom. Toxicon. 1998 Nov; 36: 1529-1538.
Six DA, Dennis EA. The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochim Biophys Acta. 2000 Oct 31; 1488(1-2):1-19.
Gutierrez JM, Leon G, Burnouf T. Antivenoms for the treatment of snakebite envenomings: the road ahead. Biologicals. 2011 May; 39(3): 129-142.
Rucavado A, Escalante T, Shannon JD, Ayala-Castro CN, Villalta M, Gutiérrez JM, et al. Efficacy of IgG and F(ab’)2 antivenoms to neutralize snake venom-induced local tissue damage as assessed
by the proteomic analysis of wound exudate. J Proteome Res. 2012 Jan 1; 11(1): 292-305.
Martz W. Plants with a reputation against snakebite. Toxicon. 1992 Oct; 30(10): 1131-1142.
Mors WB, Nascimento MC, Pereira BM, Pereira NA. Plant natural products active against snake bite--the molecular approach. Phytochemistry. 2000 Nov; 55(6): 627- 642.
Otero R, Núñez V, Barona J, Fonnegra R, Jiménez SL, Osorio RG, et al. Snakebites and ethnobotany in the northwest region of Colombia. Part III: neutralization of the haemorrhagic effect of Bothrops atrox venom. J Ethnopharmacol. 2000 Nov; 73(1-2): 233-241.
Coe FG, Anderson GJ. Snakebite ethnopharmacopoeia of eastern Nicaragua. J Ethnopharmacol. 2005 Jan 4; 96(1-2): 303-323.
Pithayanukul P, Ruenraroengsak P, Bavovada R, Pakmanee N, Suttisri R, Saen-oon S. et al. Inhibition of Naja kaouthia venom activities by plant polyphenols. J Ethnopharmacol. 2005 Mar 21; 97(3): 527-533.
Toyama DO, Marangoni S, Diz-Filho EB, Oliveira SC, Toyama MH, et al. Effect of umbelliferone (7-hydroxycoumarin, 7-HOC) on the enzymatic, edematogenic and necrotic activities of secretory phospholipase A2 (sPLA2) isolated from Crotalus durissus collilineatus venom. Toxicon. 2009 Mar 15; 53(4): 417-426.
Pereañez JA, Núñez V, Patiño AC, Londoño, M, Quintana JC, et al. Inhibitory effects of plant phenolic compounds on enzymatic and cytotoxic activities induced by a snake venom phospholipase A2. Vitae. 2011 Sep-Dec; 18(3): 295-304.
Carvalho BM, Santos JD, Xavier BM, Almeida JR, Resende LM, Martins W, et al. Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules. Biomed Res Int. 2013 Sep 22; 2013: 153045.
Pereañez JA, Lobo-Echeverri T, Rojano B, Vargas L, Fernández M, Gaviria, CA, et al. Correlation of the inhibitory activity of phospholipase A2snake venom and the antioxidant activity of Colombian plant extracts. Rev Bras Farmacogn. 2010 Dec; 20(6): 910-916
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Vitae
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice and Open Access Statement
The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the Creative Commons license, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.
Authors declare that:
-
They are the intellectual property owners and are responsible for all the information stated in the article.
-
This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.
-
They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.
-
They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.
-
Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.
-
They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.
-
They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.
-
They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.
-
After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.
Conflict of interest: Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.
